13F-HR filed by GSK plc
GSK plc filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-14, with 13 holding rows worth $599,153,380.
- Accession
- 0001999371-26-010742
- Filer
- CIK 1131399
- Filed
- 2026-05-14
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2026
A holdings report, 13 entries on the cover page, a total value of $599,153,380 stated on the cover page (in dollars after the unit check, H1), rows summing to $599,153,380 with VALUE read as dollars as filed, 13F file number 028-26280. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CRISPR THERAPEUTICS AG NAMEN AKT | H17182108 | Stock | 3,220,627 | $153,205,226 | dollars as filed | |
| WAVE LIFE SCIENCES LTD SHS | Y95308105 | Stock | 18,245,691 | $132,281,260 | dollars as filed | |
| BIONTECH SE SPONSORED ADS | 09075V102 | ADR | 889,824 | $79,087,557 | dollars as filed | |
| VIR BIOTECHNOLOGY INC | 92764N102 | COM | 8,550,954 | $76,616,548 | dollars as filed | |
| IDEAYA BIOSCIENCES INC COM | 45166A102 | Stock | 1,333,333 | $44,426,656 | dollars as filed | |
| LYELL IMMUNOPHARMA INC COM NEW | 55083R203 | Stock | 1,512,659 | $30,343,940 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 340,434 | $22,438,005 | dollars as filed | |
| SPERO THERAPEUTICS INC | 84833T103 | COM | 9,190,606 | $21,506,018 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 1,785,714 | $13,696,426 | dollars as filed | |
| CVRX INC | 126638105 | COMMON STOCK | 1,007,583 | $9,531,735 | dollars as filed | |
| BICYCLE THERAPEUTICS PLC-ADR | 088786108 | SPONSORED ADS | 1,529,561 | $7,097,163 | dollars as filed | |
| NKARTA INC | 65487U108 | COMMON STOCK | 3,150,732 | $6,648,045 | dollars as filed | |
| REGENXBIO INC | 75901B107 | COM | 271,456 | $2,274,801 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001999371-26-010742 | this filing | 2026-05-14 | acceptance time not in the bulk data set |